『Hepatitis B treatment ‘Apoville’ launched』
KyungDong Pharm Co., Ltd. is a chronic hepatitis B treatment drug.Apoville Town’ was released on July 1. Apovil tablets are a hepatitis B treatment containing ‘Adefovir dipivoxil 10mg’ and are a preparation with very few adverse reactions and side effects. Apovil tablets are the only drug that is effective in patients showing resistance to other existing hepatitis B treatments, and can treat hepatitis B without cross-resistance with other drugs.
Apovil tablets improve overall virological, biochemical, histological, and serological responses regardless of whether hepatitis B progresses. In addition, it is an agent that can show excellent therapeutic effects by maintaining continuous reduction of HBV DNA and normalization of ALT levels in lamivudine-resistant patients through single or combined treatment.
Apovil Tablet is a purely domestic product produced directly from raw materials using KyungDong Pharm Co., Ltd.'s outstanding technology, and is expected to play an active role in the hepatitis B treatment market in the future.
♠ Product Information ♠
▷ Product name: Apovil tablets
▷ Ingredient content: Adefovir dipivoxil 10mg
▷ Efficacy: Serum aminotransferase (ALT or AST) is continuously elevated or histologically
Treatment of patients with chronic hepatitis B virus infection with evidence of active disease
▷ Dosage: Adults, 1 tablet (10mg) once a day
▷ Insurance price: 5,197 won/tablet
▷ Insurance code: 648102890
▷ Packaging unit: 30 tablets
* For further details, please refer to the product manual.